Reset Map4 Results
B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, 215123 China SuZhou, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.
8/9F, 288 Jiangyun Road, Suzhou Industrial Park Suzhou, Jiangsu, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.
68 Chunpu Road, Bldg.3, 1st Floor, Industrial Park, Suzhou, China China/Jiangsu Province/Suzhou City, 215123 ChinaFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.
3000 EASTPARK BOULEVARD SUITE 500B Cranbury, NJ, 08512 United StatesFrom Molecule to Medicine—Your Partner in Small Molecules, Biologics, and Nucleic Acids Crystal Pharmatech, founded in 2010, is a global contract research organization with over 300 employees and four R&D centers in New Jersey (USA), San Francisco (USA), Toronto (Canada), and Suzhou (China). Collectively, these sites provide integrated support for pharmaceutical and biotechnology companies worldwide. Our capabilities span three specialized platforms: in small molecules, we offer API solid-state research and crystallization, preformulation, formulation development, and GMP manufacturing and supply; through Crystal Bio Solutions, we deliver bioanalytical and biomarker testing, biologics CMC analytics, and quantitative clinical pharmacology; and through Crystal NAX, we provide end-to-end solutions for nucleic acid therapeutics. With an average of 20 years of experience, our scientific leadership team has successfully delivered over 100 NCEs and 15 drug products for global pharmaceutical companies. We have served more than 1,000 clients, supporting over 2,000 new chemical entities. Crystal Pharmatech (In Small Molecules) — Global Leader in Solid-State Research, Preformulation & Formulation We offer solid-state research, preformulation, and formulation of small-molecule drugs. We have supported 1,000+ clients and worked on more than 2,000 compounds across developability assessment, solid-form screening, preformulation, formulation development, and clinical trial materials (CTM) through to commercial manufacturing. With four R&D centers in New Jersey, California, Toronto, and Suzhou, and a team of approximately 300 professionals, we combine deep crystal-form expertise with both conventional and enabling technologies—such as amorphous solid dispersion—to unlock bioavailability and manufacturability. Our cGMP facilities operate to FDA, EMA, and NMPA standards, ensuring phase-appropriate quality from early studies through scale-up. Leveraging our unique expertise, we partner with you to design and develop the most suitable crystal form and formulation for downstream development. Our guiding principle—“get the crystal form and formulation right the first time for Phase I”—accelerates IND filing and Phase I entry while minimizing the need for human pharmacokinetic (PK) bridging studies, saving time and reducing costs as programs advance to Phase II and beyond. Crystal Bio Solutions — Your Trusted Partner for Biologics CMC Analytical, Bioanalysis & QCP Crystal Bio Solutions (wholly owned) delivers Quantitative Clinical Pharmacology (QCP), Bioanalytical & Biomarker, and Biologics CMC Analytical services. Modalities include antibodies, bispecifics and multispecifics, proteins, ADCs, cell and gene therapies (CGT), mRNA, LNPs, nucleotides, vaccines, and viruses—providing decision-ready data through sound science and operational excellence. Crystal NAX — Unlocking the Potential of Nucleic Acid Therapeutics Crystal NAX (wholly owned) provides end-to-end support for nucleic acid therapeutics—from early R&D to clinical development—covering xRNA, siRNA, and other oligonucleotides; LNP delivery and formulation; and advanced analytics. Its mission is to accelerate innovation in nucleic acid therapies and help deliver medicines to patients faster. Together, Crystal Pharmatech offers a seamless path from discovery to clinic for small molecules, biologics, and nucleic acids—your partner of choice from molecule to medicine.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.